Shockwave Medical, Inc. (NASDAQ:SWAV – Free Report) – Research analysts at Leerink Partnrs decreased their Q3 2024 earnings per share estimates for Shockwave Medical in a research report issued on Thursday, March 28th. Leerink Partnrs analyst M. Kratky now expects that the company will post earnings of $1.58 per share for the quarter, down from […]
Stock analysts at CL King initiated coverage on shares of Shockwave Medical (NASDAQ:SWAV – Get Free Report) in a note issued to investors on Wednesday, MarketBeat.com reports. The firm set a “buy” rating and a $368.00 price target on the stock. CL King’s price objective would indicate a potential upside of 13.01% from the company’s […]
Shockwave Medical (NASDAQ:SWAV) is a Santa Clara-based medical device company that is engaged in the development and commercialization of intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and .